PubRank

K U Knowlton

Author PubWeight™ 34.54‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc Natl Acad Sci U S A 1991 5.60
2 Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response. FASEB J 1991 3.29
3 Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes. A paracrine mechanism for myocardial cell hypertrophy. J Biol Chem 1990 2.64
4 Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat Med 1999 2.50
5 Transcriptional regulation during cardiac growth and development. Annu Rev Physiol 1993 2.33
6 Cleavage of Poly(A)-binding protein by coxsackievirus 2A protease in vitro and in vivo: another mechanism for host protein synthesis shutoff? J Virol 1999 1.98
7 Nitric oxide inhibits dystrophin proteolysis by coxsackieviral protease 2A through S-nitrosylation: A protective mechanism against enteroviral cardiomyopathy. Circulation 2000 1.44
8 Gq- and ras-dependent pathways mediate hypertrophy of neonatal rat ventricular myocytes following alpha 1-adrenergic stimulation. J Biol Chem 1994 1.41
9 Cardioselective infection with coxsackievirus B3 requires intact type I interferon signaling: implications for mortality and early viral replication. Circulation 2001 1.31
10 NF-kappaB-mediated inhibition of apoptosis is required for encephalomyocarditis virus virulence: a mechanism of resistance in p50 knockout mice. J Virol 1998 1.20
11 Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy. J Clin Invest 1998 1.16
12 Low-level expression of a mutant coxsackieviral cDNA induces a myocytopathic effect in culture: an approach to the study of enteroviral persistence in cardiac myocytes. Circulation 1998 1.10
13 Adrenergic control of circulating lymphocyte subpopulations. Effects of congestive heart failure, dynamic exercise, and terbutaline treatment. J Clin Invest 1990 1.06
14 The immune system in viral myocarditis: maintaining the balance. Circ Res 1999 1.05
15 Enteroviral protease 2A directly cleaves dystrophin and is inhibited by a dystrophin-based substrate analogue. J Biol Chem 2000 1.00
16 Dissociation of sarcoglycans and the dystrophin carboxyl terminus from the sarcolemma in enteroviral cardiomyopathy. Circ Res 2000 0.91
17 Cardiovascular molecular biology. Introduction to the series. Circulation 1989 0.89
18 Inflammatory pathways and cardiac repair: the affliction of infarction. Nat Med 1999 0.79
19 Treatment of coxsackievirus-B3-infected BALB/c mice with the soluble coxsackie adenovirus receptor CAR4/7 aggravates cardiac injury. J Mol Med (Berl) 2006 0.78
20 Alpha 1-adrenergic stimulation inhibits 3,5,3'-triiodothyronine-induced expression of the rat heart sarcoplasmic reticulum Ca2+ adenosine triphosphatase gene. Endocrinology 1997 0.77
21 Enteroviral cardiomyopathy: bad news for the dystrophin-glycoprotein complex. Herz 2000 0.76
22 The immune response following myocardial infarction: a role for T-cell-mediated myocyte damage. J Mol Cell Cardiol 2000 0.75
23 Regulated expression of a contractile protein gene correlates with recovery of contractile function after reversible metabolic inhibition in cultured myocytes. J Mol Cell Cardiol 1995 0.75
24 Two brothers with unexplained cardiomegaly Initial clues to the molecular basis of a hereditary cardiac disease. Trends Cardiovasc Med 2011 0.75
25 Peripartum vascular collapse Dissection of a genetic disease. Trends Cardiovasc Med 2011 0.75